Approval · Notice of Compliance 3600 · 2003
CIALIS: Notice of Compliance 3600
Issued September 17, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3600
- Date
- September 17, 2003
- Company
- Lilly Icos Llc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Cgmp-specific phosphodiesterase type 5 inhibitor